Increased c-kit (CD117) expression in malignant mammary phyllodes tumors
- 1 July 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (7) , 827-831
- https://doi.org/10.1038/modpathol.3800125
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Periductal Stromal TumorThe American Journal of Surgical Pathology, 2003
- Malignant phyllodes tumours show stromal overexpression of c‐myc and c‐kitThe Journal of Pathology, 2003
- Increased p53 Protein Expression in Malignant Mammary Phyllodes TumorsLaboratory Investigation, 2002
- CD34, CD117, and Actin Expression in Phyllodes Tumor of the BreastJournal of Surgical Research, 2000
- Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or LeiomyosarcomasThe American Journal of Pathology, 1999
- Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissuesBritish Journal of Cancer, 1996
- Phyllodes tumorsThe American Journal of Surgery, 1993
- Breast cancer is associated with loss of the c‐kit oncogene productInternational Journal of Cancer, 1992
- Phyllodes tumor of the breast: A clinicopathologic study of 34 casesJournal of Surgical Oncology, 1990
- Ultrasound, x-ray mammography, and histopathology of cystosarcoma phylloides.Radiology, 1983